Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Gains from Investment Securities (2021 - 2025)

Rxo's Gains from Investment Securities history spans 5 years, with the latest figure at -$31.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 66.67% year-over-year to -$31.0 million; the TTM value through Dec 2025 reached -$11.0 million, down 375.0%, while the annual FY2025 figure was -$11.0 million, 375.0% down from the prior year.
  • Gains from Investment Securities reached -$31.0 million in Q4 2025 per RXO's latest filing, down from -$2.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $94.0 million in Q3 2024 to a low of -$93.0 million in Q4 2024.
  • Average Gains from Investment Securities over 5 years is -$1.2 million, with a median of $0.0 recorded in 2022.
  • The largest YoY upside for Gains from Investment Securities was 4600.0% in 2024 against a maximum downside of 830.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$3.0 million in 2021, then soared by 300.0% to $6.0 million in 2022, then tumbled by 266.67% to -$10.0 million in 2023, then tumbled by 830.0% to -$93.0 million in 2024, then surged by 66.67% to -$31.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Gains from Investment Securities are -$31.0 million (Q4 2025), -$2.0 million (Q3 2025), and $5.0 million (Q2 2025).